You can buy or sell CLVS and other stocks, options, ETFs, and crypto commission-free!
Clovis Oncology, Inc. Common Stock, also called Clovis Oncology, is a commercial stage biotechnology company, which engages in the acquisition, development, and commercialization of cancer treatments in the United States, Europe, and other markets. Read More Its product development programs target specific subsets of cancer, and simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from its use. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.
52 Week High
52 Week Low
Expected Feb 25, Pre-Market